{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:52:26Z","timestamp":1781272346879,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fogarty International Center of the National Institutes of Health","award":["D43TW009343"],"award-info":[{"award-number":["D43TW009343"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intensive adherence counseling (IAC) is the global standard of care for people living with human immunodeficiency virus (PLHIV) who have unsuppressed VL after \u2265\u20096 months of first-line anti-retroviral therapy (ART). We investigated whether the number of IAC sessions is associated with suppressed VL among PLHIV in Kampala, Uganda.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a nested case-control study among PLHIV with unsuppressed VL after \u2265\u20093 IAC sessions (cases) and a 2:1 random sample of PLHIV with suppressed VL after \u2265\u20093 IAC sessions (controls). Unsuppressed VL was defined as VL\u2009\u2265\u20091000 copies\/ml. We performed multivariable logistic regression to identify factors that differed significantly between cases and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Demographic and clinical characteristics were similar among the 16 cases and 32 controls including mean age, sex, baseline CD4 count, VL before IAC, and WHO clinical stage. Only the number of IAC sessions differed significantly between cases and controls in unadjusted (p\u2009=\u20090.012) and adjusted (p\u2009=\u20090.016) analyses. Each unit increase in IAC session was associated with unsuppressed VL (Adjusted odds ratio 5.09; 95% CI 1.35\u201319.10).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>VL remained unsuppressed despite increasing IAC frequency. The fidelity to standardized IAC protocol besides drug resistance testing among PLHIV with unsuppressed VL before IAC commencement should be examined.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-023-00583-3","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T02:03:56Z","timestamp":1702951436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors for unsuppressed viral load after intensive adherence counseling among HIV infected persons in Kampala, Uganda: a nested case\u2013control study"],"prefix":"10.1186","volume":"20","author":[{"given":"Jonathan","family":"Izudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"1","key":"583_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/QAI.0b013e31829f05ac","volume":"64","author":"K Bonner","year":"2013","unstructured":"Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review. JAIDS J Acquir Immune Defic Syndr. 2013;64(1):74\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"583_CR2","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1186\/s12879-021-06862-6","volume":"21","author":"Z Lukyamuzi","year":"2021","unstructured":"Lukyamuzi Z, Etajak S, Katairo T, Mukunya D, Tetui M, Ssenyonjo A, et al. Effect and implementation experience of intensive adherence counseling in a public HIV care center in Uganda: a mixed-methods study. BMC Infect Dis. 2021;21:1168.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"583_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-12366-4","volume":"21","author":"G Ndikabona","year":"2021","unstructured":"Ndikabona G, Alege JB, Kirirabwa NS, Kimuli D. Unsuppressed viral load after intensive adherence counselling in rural eastern Uganda; a case of Kamuli district, Uganda. BMC Public Health. 2021;21(1):1\u201313.","journal-title":"BMC Public Health"},{"issue":"1","key":"583_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/hiv.12790","volume":"21","author":"J Birungi","year":"2020","unstructured":"Birungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C, et al. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda. HIV Med. 2020;21(1):21\u20139.","journal-title":"HIV Med"},{"key":"583_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.08.057","author":"B Kikaire","year":"2021","unstructured":"Kikaire B, Ssemanda M, Asiimwe A, Nakanwagi M, Seruwagi G, Lawoko S, et al. HIV viral suppression viral load suppression following intensive adherence counseling among people living on treatment at military-managed health facilities in Uganda. Int J Infect Dis. 2021. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.057.","journal-title":"Int J Infect Dis."},{"issue":"8","key":"583_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002240","volume":"3","author":"J Izudi","year":"2023","unstructured":"Izudi J, Castelnuovo B, King R, Cattamanchi A. Impact of intensive adherence counseling on viral load suppression and mortality among people living with HIV in Kampala, Uganda: a regression discontinuity design. PLOS Glob Public Health. 2023;3(8): e0002240.","journal-title":"PLOS Glob Public Health"},{"issue":"12","key":"583_CR7","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.5588\/ijtld.22.0357","volume":"26","author":"J Izudi","year":"2022","unstructured":"Izudi J, Sheira LA, Bajunirwe F, McCoy SI, Cattamanchi A. Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB. Int J Tuberc Lung Dis. 2022;26(12):1188\u201390.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"583_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5588\/pha.22.0047","volume":"13","author":"J Izudi","year":"2023","unstructured":"Izudi J, Bajunirwe F, Cattamanchi A. Increase in rifampicin resistance among people previously treated for TB. Public Health Act. 2023;13(1):4\u20136.","journal-title":"Public Health Act"},{"issue":"2","key":"583_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116144","volume":"10","author":"K Jobanputra","year":"2015","unstructured":"Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS ONE. 2015;10(2): e0116144.","journal-title":"PLoS ONE"},{"key":"583_CR10","first-page":"91","volume":"13","author":"G Bisetegn","year":"2021","unstructured":"Bisetegn G, Arefaynie M, Mohammed A, Fentaw Z, Muche A, Dewau R, et al. Predictors of virological failure after adherence-enhancement counseling among first-line adults living with HIV\/AIDS in Kombolcha Town, Northeast Ethiopia. HIV\/AIDS (Auckland, NZ). 2021;13:91\u20137.","journal-title":"HIV\/AIDS (Auckland, NZ)."},{"issue":"1","key":"583_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-020-00324-w","volume":"18","author":"PO Bessong","year":"2021","unstructured":"Bessong PO, Matume ND, Tebit DM. Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview. AIDS Res Ther. 2021;18(1):1.","journal-title":"AIDS Res Ther"},{"issue":"9","key":"583_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/tmi.12741","volume":"21","author":"MP Fox","year":"2016","unstructured":"Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, et al. Intensive adherence counselling for HIV-infected individuals failing second\u2010line antiretroviral therapy in Johannesburg, South Africa. Trop Med Int Health. 2016;21(9):1131\u20137.","journal-title":"Trop Med Int Health"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00583-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T14:05:13Z","timestamp":1702994713000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00583-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00583-3","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a sub-analysis of data from a parent study. Ethical approval was obtained from the Infectious Diseases Institute Research Ethics Committee (#IDI-REC-2022-18) and the Uganda National Council for Science and Technology (#HS25553ES). Administrative clearance was from the Directorate of Public Health and Environment, KCCA (#DPHE\/KCCA\/1301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}